Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Ranitidine, sold under the brand name Zantac among others, is a medication used to decrease stomach acid production. It is used in the treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It can be given by mouth, injection into a muscle, or injection into a vein.
The analysis highlights History, Applications, Products and Standards as prominent areas in the source structure around Ranitidine.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Ranitidine shows recurring relationship patterns in the source. For example, Ranitidine → AH19065, Allen, Both, CYP450, England, French, Glaxo, Glaxo Group Research, Glaxo Wellcome, GlaxoSmithKline, GSK, H2, Hanbury's Ltd, Hanburys, Its, John Bradshaw, Kline, November, Sir James Black, Smith Another extracted example is Ranitidine → Apotex Inc, Canada, Drug Administration, EMA, European Commission, European Union-wide, FDA, Health Canada, In June, In September, N-nitrosodimethylamine, NDMA, Pro Doc Limitée, Sandoz Canada, Sanis Health Inc, Sivem Pharmaceuticals ULC, The European Medicines Agency, US Food, Valisure, Zantac. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
ndma 2019 may drug medicines products h2 fda united levels found 2020 risk states receptor recalled effects drugs issued zantac
TTTA extracted 155 structured relationships around Ranitidine. Examples in this analysis include Ranitidine → 3D model (JSmol) → Interactive image and Ranitidine → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Ranitidine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Ranitidine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Ranitidine | ATC code | A02BA02 (WHO) A02BA07 (WHO) (ranitidine bismuth citrate) | 1.00 | infobox |
| Ranitidine | Bioavailability | 50% (by mouth) | 1.00 | infobox |
| Ranitidine | CAS Number | 66357-35-5 | 1.00 | infobox |
| Ranitidine | CAS Number | HCl: 66357-59-3 | 1.00 | infobox |
| Ranitidine | ChEBI | CHEBI:8776 | 1.00 | infobox |
| Ranitidine | ChEBI | HCl: CHEBI:8777 | 1.00 | infobox |
| Ranitidine | ChEMBL | ChEMBL1790041 | 1.00 | infobox |
| Ranitidine | ChEMBL | HCl: ChEMBL2110372 | 1.00 | infobox |
| Ranitidine | ChemSpider | 4863 | 1.00 | infobox |
| Ranitidine | ChemSpider | HCl: 43590 | 1.00 | infobox |
| Ranitidine | CompTox Dashboard (EPA) | DTXSID8045191 | 1.00 | infobox |
| Ranitidine | Drug class | Histamine H2 receptor antagonist, aka H2 blocker | 1.00 | infobox |
| Ranitidine | DrugBank | DB00863 | 1.00 | infobox |
| Ranitidine | DrugBank | HCl: DBSALT000487 | 1.00 | infobox |
| Ranitidine | ECHA InfoCard | 100.060.283 | 1.00 | infobox |
| Ranitidine | Elimination half-life | 2–3 hours | 1.00 | infobox |
| Ranitidine | Excretion | 30–70% kidney | 1.00 | infobox |
| Ranitidine | Formula | C13H22N4O3S | 1.00 | infobox |
| Ranitidine | IUPHAR/BPS | 1234 | 1.00 | infobox |
| Ranitidine | KEGG | D00422 | 1.00 | infobox |
| Ranitidine | KEGG | HCl: D00673 | 1.00 | infobox |
| Ranitidine | Legal status | AU: S4 (Prescription only) / S2 (Pharmacy Medicine) | 1.00 | infobox |
| Ranitidine | Legal status | CA: ℞-only / OTC | 1.00 | infobox |
| Ranitidine | Legal status | US: ℞-only / OTC | 1.00 | infobox |
| Ranitidine | Legal status | EU: Rx-only | 1.00 | infobox |
| Ranitidine | License data | US DailyMed: Ranitidine | 1.00 | infobox |
| Ranitidine | MedlinePlus | a601106 | 1.00 | infobox |
| Ranitidine | Metabolism | Liver: FMOs, including FMO3; other enzymes | 1.00 | infobox |
The concept neighborhoods around Ranitidine bring nearby vocabulary together. In this analysis, examples include Ndma, Products and Recalled. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Ranitidine, one of the stronger structural bridges in this analysis connects Ranitidine with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Ranitidine to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications, Products & Standards, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Ranitidine · EN edition · Analysis: TopicsToTalkAbout